CClinicalTrials.gg
CompletedNCT05080894Updated Apr 18, 2024

Virtual Reality Rehabilitation for Patients With Anterior Cruciate Ligament Reconstruction

An interventional study of Virtual reality in Knee Injuries, sponsored by Institut d'Investigacions Biomèdiques August Pi i Sunyer. Completed at 1 site in Spain. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2024-04-18.

Sponsored by Institut d'Investigacions Biomèdiques August Pi i Sunyer · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The purpose of this study is to ascertain whether 4 weeks of daily virtual-reality-based rehabilitation at home improves disability in the early stages of recovery from anterior cruciate ligament reconstruction surgery compared with standard care.

Read the detailed description

After being informed about the study and potential risks and benefits, patients giving written informed consent will be randomized to one of two groups in a 1:1 ratio. The treatment group will perform daily a 20-minute rehabilitation session in virtual reality, in which they will observe their virtual body performing a series of exercises they would otherwise be unable to perform in real life. Both groups will also undergo the standard rehabilitation protocol. The investigators will assess for differences between groups in self-reported disability, knee range of motion, and quadriceps strength at baseline, 4 weeks, 12 weeks and 9 months.

02

Conditions studied

  • Knee Injuries

Browse trials for

Keywords

  • virtual reality
  • embodiment
  • rehabilitation
  • anterior cruciate ligament reconstruction
03

In context

Knee Injuries

249 studies on the registry are indexed under Knee Injuries; 48 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 160 interventional studies indexed under Knee Injuries.

Browse Knee Injuries studies →

Lead sponsor

Institut d'Investigacions Biomèdiques August Pi i Sunyer is the lead sponsor of 9 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 18-40 (either sex)
  • Post-operative anterior cruciate ligament reconstruction (autograft), either bone-patellar tendon-bone graft or semitendinosus (hamstring) graft

Exclusion criteria

Exclusion Criteria:

  • Patients with significant cognitive deficit (MEC\<24).
  • Patients with epilepsy or severe vision problems
  • Pregnant patients
  • Previous surgery on the reconstructed knee, excluding arthroscopy
  • Previous anterior cruciate ligament reconstruction on either knee
  • Sustained concurrent injury to the contralateral knee
  • Concomitant collateral ligament and/or meniscal repair
  • Presence of symptomatic tibiofemoral osteoarthritis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Virtual reality

    Daily 20-minute sessions of virtual reality based rehabilitation for the first 4 weeks post-operatively + standard rehabilitation protocol

    Device: Virtual reality

  • No intervention
    Standard intervention

    Standard rehabilitation protocol only

Interventions

  • DeviceVirtual reality

    Embodiment of a healthy virtual body in virtual reality and action observation/motor imagery of the subject's virtual body performing high-level lower limb exercises.

06

What researchers measure

Primary outcomes

  1. The International Knee Documentation Committee (IKDC) Subjective Knee Form

    Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Time frame: Baseline (day 1 post-surgery)

  2. The International Knee Documentation Committee (IKDC) Subjective Knee Form

    Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Time frame: 4 weeks

  3. The International Knee Documentation Committee (IKDC) Subjective Knee Form

    Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Time frame: 12 weeks

  4. The International Knee Documentation Committee (IKDC) Subjective Knee Form

    Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Time frame: 9 months

Secondary outcomes

  1. Isometric quadriceps strength

    Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)

    Time frame: Baseline

  2. Isometric quadriceps strength

    Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)

    Time frame: 4 weeks

  3. Isometric quadriceps strength

    Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)

    Time frame: 12 weeks

  4. Isometric quadriceps strength

    Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)

    Time frame: 9 months

  5. Knee extension active range of motion

    Measured with a digital goniometer (smartphone app)

    Time frame: Baseline

  6. Knee extension active range of motion

    Measured with a digital goniometer (smartphone app)

    Time frame: 4 weeks

  7. Knee extension active range of motion

    Measured with a digital goniometer (smartphone app)

    Time frame: 12 weeks

  8. Knee extension active range of motion

    Measured with a digital goniometer (smartphone app)

    Time frame: 9 months

  9. Time taken to return to sporting activity

    Taken retrospectively at 9 months, number of days from surgery to full return to sport

    Time frame: 9 months

  10. Kinesiophobia

    Fear of movement as measured with the Tampa scale of kinesiophobia

    Time frame: Baseline

  11. Kinesiophobia

    Fear of movement as measured with the Tampa scale of kinesiophobia

    Time frame: 4 weeks

  12. Kinesiophobia

    Fear of movement as measured with the Tampa scale of kinesiophobia

    Time frame: 12 weeks

  13. Kinesiophobia

    Fear of movement as measured with the Tampa scale of kinesiophobia

    Time frame: 9 months

07

Study locations

1 site
  • IDIBAPS
    Barcelona, 08036, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05080894
Lead sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Collaborators
Fundación Mutua Madrileña
Responsible party
Prof. Maria V. Sanchez-Vives (Professor, Institut d'Investigacions Biomèdiques August Pi i Sunyer) — Principal investigator
First posted
Oct 18, 2021
Start date
Oct 1, 2021
Primary completion
Nov 15, 2023
Completion
Dec 15, 2023
Last update
Apr 18, 2024

Study contacts

Maria V. Sanchez-Vives
principal investigator · Institut d'Investigacions Biomèdiques August Pi i Sunyer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion